Next Issue
Volume 160, 01
Previous Issue
Volume 160, 01
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
SANPP
Volume 160
Issue 2
share announcement
Swiss Archives of Neurology, Psychiatry and Psychotherapy is published by MDPI from Volume 176 Issue 1 (2026). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with the previous journal publisher.

Swiss Arch. Neurol. Psychiatry Psychother., Volume 160, Issue 2 (01 2009) – 10 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
124 KB  
Communication
Aristidis Veves, Rayaz A. Malik, editors: Diabetic Neuropathy. Clinical Management
by EMH Swiss Medical Publishers Ltd.
Swiss Arch. Neurol. Psychiatry Psychother. 2009, 160(2), 82; https://doi.org/10.4414/sanp.2009.02049 - 1 Jan 2009
Abstract
Der Untertitel des Buches ist etwas irreführend: Es wird weit mehr als das Rüstzeug zur klinischen Diagnose und Therapie der diabetischen Neuropathie besprochen [...] Full article
124 KB  
Communication
R. Nieuwenhuys, J. Voogd, C. van Huijzen: The Human Central Nervous System
by EMH Swiss Medical Publishers Ltd.
Swiss Arch. Neurol. Psychiatry Psychother. 2009, 160(2), 82; https://doi.org/10.4414/sanp.2009.02048 - 1 Jan 2009
Cited by 1
Abstract
Das «Zentralnervensystem des Menschen» von Nieuwenhuys, Voogd und van Huijzen – auf die Neuauflage des 1988 letztmals erschienenen «Atlas mit Begleittext» haben seine Anhänger lange gewartet [...] Full article
124 KB  
Communication
Marco Mumenthaler, Heinrich Mattle: Neurologie
by EMH Swiss Medical Publishers Ltd.
Swiss Arch. Neurol. Psychiatry Psychother. 2009, 160(2), 81; https://doi.org/10.4414/sanp.2009.02047 - 1 Jan 2009
Abstract
Der Klassiker schlechthin, wenn es um kon - zise, praktikable und zugleich umfassende Information geht [...] Full article
124 KB  
Communication
Gabriele Arendt: Neurologische und neuropsychiatrische Aspekte der HIV-Infektion. Grundlagen, Diagnostik und Therapie
by EMH Swiss Medical Publishers Ltd.
Swiss Arch. Neurol. Psychiatry Psychother. 2009, 160(2), 81; https://doi.org/10.4414/sanp.2009.02046 - 1 Jan 2009
Abstract
Es gibt nur wenige deutschsprachige Werke zum Thema der neurologischen Komplika - tionen der HIV-Infektion [...] Full article
148 KB  
Tutorial
Neurologist-in-training
by Hans H. Jung
Swiss Arch. Neurol. Psychiatry Psychother. 2009, 160(2), 77-80; https://doi.org/10.4414/sanp.2009.02045 - 1 Jan 2009
Viewed by 30
Abstract
The aim of this section is to prepare the neurologist- in-training for the FMH examination, to confront her or him with specific problems of everyday neurological practice and to give him or her updates on recent controversies in clinical neurology [...] Full article
►▼ Show Figures

Figure 1

120 KB  
Communication
Could transient global amnesia be an epileptic phenomenon?
by Daniel Eschle and H.-G. Wieser
Swiss Arch. Neurol. Psychiatry Psychother. 2009, 160(2), 73-76; https://doi.org/10.4414/sanp.2009.02040 - 1 Jan 2009
Cited by 1 | Viewed by 40
Abstract
This mini-review entertains the concept that transient global amnesia (TGA) could possibly be part of the spectrum of transient epileptic amnesia (TEA), which is considered the most important differential diagnosis by many clinicians. To support this hypothesis we analysed EEG data, where conventional [...] Read more.
This mini-review entertains the concept that transient global amnesia (TGA) could possibly be part of the spectrum of transient epileptic amnesia (TEA), which is considered the most important differential diagnosis by many clinicians. To support this hypothesis we analysed EEG data, where conventional scalp recording was unrevealing, but nasopharyngeal electrodes demonstrated epileptic discharges in the medial temporal lobe, the region implicated in memory dysfunction during transient global amnesia. Full article
135 KB  
Article
Recommandations pour le traitement de la maladie de Parkinson
by Groupe de travail de la Commission de thérapie de la Société Suisse de Neurologie (SSN)
Swiss Arch. Neurol. Psychiatry Psychother. 2009, 160(2), 66-72; https://doi.org/10.4414/sanp.2009.02041 - 1 Jan 2009
Cited by 1 | Viewed by 45
Abstract
Il y a 10 ans, notre groupe de travail a publié des recommandations pour le traitement des patients parkinsoniens3, et les a révisées une première fois il y a 4 ans [...] Full article
639 KB  
Article
History of the Swiss Neurological Society in the context of the national and international development of neurology
by Claudio L. Bassetti and P. O. Valko
Swiss Arch. Neurol. Psychiatry Psychother. 2009, 160(2), 52-65; https://doi.org/10.4414/sanp.2009.02042 - 1 Jan 2009
Cited by 7 | Viewed by 42
Abstract
Long before the founding of the Swiss Neurolo gical Society (SNS) in 1908, Switzerland had made important contributions to the clinical and experimental neurosciences [1, 2] [...] Full article
►▼ Show Figures

Figure 1

186 KB  
Review
Neurorehabilitation bei Multipler Sklerose
by Serafin Beer and J. Kesselring
Swiss Arch. Neurol. Psychiatry Psychother. 2009, 160(2), 46-51; https://doi.org/10.4414/sanp.2009.02043 - 1 Jan 2009
Cited by 2 | Viewed by 35
Abstract
Multiple sclerosis is a highly complex disease with various underlying pathologies, highly variable course and often unpredictable change of disease activity. Despite the undisputed positive impact of immuno-modulatory treatment in relapsingremitting multiple sclerosis, a major part of patients will gradually accumulate pathological changes [...] Read more.
Multiple sclerosis is a highly complex disease with various underlying pathologies, highly variable course and often unpredictable change of disease activity. Despite the undisputed positive impact of immuno-modulatory treatment in relapsingremitting multiple sclerosis, a major part of patients will gradually accumulate pathological changes at different sites of the central nervous system (CNS) leading to a broad pattern of symptoms, func tional deficits and disabilities with complex interferences. In addition, patients with primary progressive course (15–20%) are not responding to these immuno- modulatory agents. Symptomatic therapies have been shown to be helpful, reducing or alle - viating certain complaints and functional deficits. The use of these agents, however, is often limited due to side effects. Considering the complexity of multiple sclerosis affecting different personal, social and economic aspects, there is a continuing need for an individualised comprehensive, multidisciplinary long-term management, which constitutes the basic concept of rehabilitation. There is strong evidence that inpatient multidisciplinary rehabilitation is effective in multiple sclerosis decreasing disability and handicap in spite of disease progression. The value of individualised physical therapy and of an adapted endurance or resistance training is also undoubted, leading to significant improvements in disability, mobility, quality of life and reducing risk of falls. For other treatment modalities, however, the impact is less clear. There are disease-specific aspects (especially thermosensitivity, fatigue), which should be considered in planning and performing rehabilitation measures in multiple sclerosis patients. The benefit may be influenced by disability level and cognitive functions. Recent findings suggest that brain plasticity with compensatory brain activation is progressively lost during the course of disease, which emphasises the need of an early evaluation of multiple sclerosis patients for the necessity of rehabilitation measures.
Full article
►▼ Show Figures

Figure 1

104 KB  
Editorial
Editorial
by EMH Swiss Medical Publishers Ltd.
Swiss Arch. Neurol. Psychiatry Psychother. 2009, 160(2), 45; https://doi.org/10.4414/sanp.2009.02044 - 1 Jan 2009
Viewed by 32
Abstract
Despite the undisputed positive impact of new drug treatment in multiple scle ro sis, the so-called disease-modifying substances, symptomatic therapy and neuro rehabilitation have a well-established role […] Full article
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-10
Previous Issue
Next Issue
Back to TopTop